Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Assets Average: 2019-2025

Historic Assets Average for Arcturus Therapeutics Holdings (ARCT) over the last 6 years, with Sep 2025 value amounting to $295.8 million.

  • Arcturus Therapeutics Holdings' Assets Average fell 22.08% to $295.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $295.8 million, marking a year-over-year decrease of 22.08%. This contributed to the annual value of $386.7 million for FY2024, which is 12.08% down from last year.
  • Arcturus Therapeutics Holdings' Assets Average amounted to $295.8 million in Q3 2025, which was down 7.71% from $320.5 million recorded in Q2 2025.
  • In the past 5 years, Arcturus Therapeutics Holdings' Assets Average ranged from a high of $479.0 million in Q1 2021 and a low of $295.8 million during Q3 2025.
  • Moreover, its 3-year median value for Assets Average was $403.7 million (2024), whereas its average is $392.6 million.
  • Per our database at Business Quant, Arcturus Therapeutics Holdings' Assets Average soared by 521.03% in 2021 and then dropped by 28.61% in 2022.
  • Arcturus Therapeutics Holdings' Assets Average (Quarterly) stood at $413.7 million in 2021, then dropped by 10.07% to $372.0 million in 2022, then climbed by 19.23% to $443.5 million in 2023, then fell by 19.43% to $357.4 million in 2024, then decreased by 22.08% to $295.8 million in 2025.
  • Its last three reported values are $295.8 million in Q3 2025, $320.5 million for Q2 2025, and $337.9 million during Q1 2025.